Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-017409
Filing Date
2025-06-16
Accepted
2025-06-16 16:53:41
Documents
2
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 form4-06162025_080636.html 4  
1 form4-06162025_080636.xml 4 4322
2 ex24-06162025_080637.htm EX-24 7094
  Complete submission text file 0001415889-25-017409.txt   13224
Mailing Address THOM. WEISEL HEALTHCARE VENTURES ONE MONTGOMERY STREET SAN FRANCISCO CA 94104
Business Address
Castelein Caley (Reporting) CIK: 0001355758 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38560 | Film No.: 251050853

Mailing Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960
Business Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960 551-321-2234
Whitehawk Therapeutics, Inc. (Issuer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)